Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;33(8):1025-1038.
doi: 10.1007/s10552-022-01591-w. Epub 2022 Jun 26.

Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis

Luke A Robles  1   2   3 , Sean Harrison  4   5 , Vanessa Y Tan  4   5 , Rhona Beynon  4   5 , Alexandra McAleenan  4   5 , Julian Pt Higgins  4   5   6 , Richard M Martin  4   5   6 , Sarah J Lewis  4   5   6
Affiliations
Review

Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis

Luke A Robles et al. Cancer Causes Control. 2022 Aug.

Abstract

Purpose: Observational studies and randomized controlled trials (RCTs) have shown an association between vitamin D levels and prostate cancer progression. However, evidence of direct causality is sparse and studies have not examined biological mechanisms, which can provide information on plausibility and strengthen the evidence for causality.

Methods: We used the World Cancer Research Fund International/University of Bristol two-stage framework for mechanistic systematic reviews. In stage one, both text mining of published literature and expert opinion identified testosterone as a plausible biological mechanism. In stage two, we performed a systematic review and meta-analysis to assess the evidence from both human and animal studies examining the effect of vitamin D on testosterone, and testosterone on advanced prostate cancer (diagnostic Gleason score of ≥ 8, development of metastasis) or prostate cancer-specific mortality.

Results: A meta-analysis of ten human RCTs showed evidence of an effect of vitamin D on total testosterone (standardised mean difference (SMD) = 0.133, 95% CI = - 0.003-0.269, I2 = 0.0%, p = 0.056). Five human RCTs showed evidence of an effect of vitamin D on free testosterone (SMD = 0.173, 95% CI = - 0.104-0.450, I2 = 52.4%, p = 0.220). Three human cohort studies of testosterone on advanced prostate cancer or prostate cancer-specific mortality provided inconsistent results. In one study, higher levels of calculated free testosterone were positively associated with advanced prostate cancer or prostate cancer-specific mortality. In contrast, higher levels of dihydrotestosterone were associated with lowering prostate cancer-specific mortality in another study. No animal studies met the study eligibility criteria.

Conclusion: There is some evidence that vitamin D increases levels of total and free testosterone, although the effect of testosterone levels within the normal range on prostate cancer progression is unclear. The role of testosterone as a mechanism between vitamin D and prostate cancer progression remains inconclusive.

Keywords: Meta-analysis; Progression; Prostate cancer; Testosterone; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

We declare there to be no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of database searches
Fig. 2
Fig. 2
Risk of bias of vitamin D-testosterone studies
Fig. 3
Fig. 3
Forest plot of vitamin D—total testosterone studies
Fig. 4
Fig. 4
Funnel plot of vitamin D—total testosterone studies
Fig. 5
Fig. 5
Forest plot of vitamin D—free testosterone studies
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Cancer Research UK. Prostate cancer statistics Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s.... Accessed 4 June 2021
    1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–1328. doi: 10.1056/NEJMoa0810084. - DOI - PubMed
    1. Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ (Clin Res ed) 2018;362:k3519. doi: 10.1136/bmj.k3519. - DOI - PMC - PubMed
    1. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi: 10.1056/NEJMoa1606220. - DOI - PubMed
    1. Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, et al. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer epidemiol biomarkers prev. 2009;18(11):2874–2881. doi: 10.1158/1055-9965.EPI-09-0544. - DOI - PubMed